Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study

Introduction Benign liver tumours and cysts (BLTCs) comprise a heterogeneous group of cystic and solid lesions, including hepatic haemangioma, focal nodular hyperplasia and hepatocellular adenoma. Some BLTCs, for example, (large) hepatocellular adenoma, are at risk of complications. Incidence of mal...

Full description

Bibliographic Details
Main Authors: Joanne Verheij, Marc G Besselink, Vincent E de Meijer, Jan N M IJzermans, D Ramsoekh, C van der Leij, Otto M van Delden, Geert Kazemier, Robert A de Man, Frans J C Cuperus, Martijn P D Haring, Evelien W Duiker, Robbert J de Haas, R Bart Takkenberg, Alicia Furumaya, Belle V van Rosmalen, Anne J Klompenhouwer, Maarten G J Thomeer, Matthijs Kramer, Mariëlle M E Coolsen, Maarten E Tushuizen, Alexander F Schaapherder, Joris I Erdmann, ID Munsterman, MD Doukas, JC Beckervordersandforth, R Miclea, ETTL Tjwa, PB van den Boezem, JHW de Wilt, S van Koeverden, AE Braat, MJ Coenraad, SSLP Crobach, S Feshtali, MC Burgmans, TM van Gulik, R Swijnenburg, KP de Jong
Format: Article
Language:English
Published: BMJ Publishing Group 2022-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/9/e055104.full
_version_ 1811210546138054656
author Joanne Verheij
Marc G Besselink
Vincent E de Meijer
Jan N M IJzermans
D Ramsoekh
C van der Leij
Otto M van Delden
Geert Kazemier
Robert A de Man
Frans J C Cuperus
Martijn P D Haring
Evelien W Duiker
Robbert J de Haas
R Bart Takkenberg
Alicia Furumaya
Belle V van Rosmalen
Anne J Klompenhouwer
Maarten G J Thomeer
Matthijs Kramer
Mariëlle M E Coolsen
Maarten E Tushuizen
Alexander F Schaapherder
Joris I Erdmann
ID Munsterman
MD Doukas
JC Beckervordersandforth
R Miclea
ETTL Tjwa
PB van den Boezem
JHW de Wilt
S van Koeverden
AE Braat
MJ Coenraad
SSLP Crobach
S Feshtali
MC Burgmans
TM van Gulik
R Swijnenburg
KP de Jong
author_facet Joanne Verheij
Marc G Besselink
Vincent E de Meijer
Jan N M IJzermans
D Ramsoekh
C van der Leij
Otto M van Delden
Geert Kazemier
Robert A de Man
Frans J C Cuperus
Martijn P D Haring
Evelien W Duiker
Robbert J de Haas
R Bart Takkenberg
Alicia Furumaya
Belle V van Rosmalen
Anne J Klompenhouwer
Maarten G J Thomeer
Matthijs Kramer
Mariëlle M E Coolsen
Maarten E Tushuizen
Alexander F Schaapherder
Joris I Erdmann
ID Munsterman
MD Doukas
JC Beckervordersandforth
R Miclea
ETTL Tjwa
PB van den Boezem
JHW de Wilt
S van Koeverden
AE Braat
MJ Coenraad
SSLP Crobach
S Feshtali
MC Burgmans
TM van Gulik
R Swijnenburg
KP de Jong
collection DOAJ
description Introduction Benign liver tumours and cysts (BLTCs) comprise a heterogeneous group of cystic and solid lesions, including hepatic haemangioma, focal nodular hyperplasia and hepatocellular adenoma. Some BLTCs, for example, (large) hepatocellular adenoma, are at risk of complications. Incidence of malignant degeneration or haemorrhage is low in most other BLTCs. Nevertheless, the diagnosis BLTC may carry a substantial burden and patients may be symptomatic, necessitating treatment. The indications for interventions remain matter of debate. The primary study aim is to investigate patient-reported outcomes (PROs) of patients with BLTCs, with special regards to the influence of invasive treatment as compared with the natural course of the disease.Methods and analysis A nationwide observational cohort study of patients with BLTC will be performed between October 2021 and October 2026, the minimal follow-up will be 2 years. During surveillance, a questionnaire regarding symptoms and their impact will be sent to participants on a biannual basis and more often in case of invasive intervention. The questionnaire was previously developed based on PROs considered relevant to patients with BLTCs and their caregivers. Most questionnaires will be administered by computerised adaptive testing through the Patient-Reported Outcomes Measurement Information System. Data, such as treatment outcomes, will be extracted from electronic patient files. Multivariable analysis will be performed to identify patient and tumour characteristics associated with significant improvement in PROs or a complicated postoperative course.Ethics and dissemination The study was assessed by the Medical Ethics Committee of the University Medical Center Groningen and the Amsterdam UMC. Local consultants will provide information and informed consent will be asked of all patients. Results will be published in a peer-reviewed journal.Study registration NL8231—10 December 2019; Netherlands Trial Register.
first_indexed 2024-04-12T04:57:35Z
format Article
id doaj.art-f9b8ce3ac97445dc82eff5ff2edfbce1
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-04-12T04:57:35Z
publishDate 2022-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-f9b8ce3ac97445dc82eff5ff2edfbce12022-12-22T03:47:06ZengBMJ Publishing GroupBMJ Open2044-60552022-09-0112910.1136/bmjopen-2021-055104Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study Joanne Verheij0Marc G Besselink1Vincent E de Meijer2Jan N M IJzermans3D RamsoekhC van der LeijOtto M van Delden4Geert Kazemier5Robert A de Man6Frans J C Cuperus7Martijn P D Haring8Evelien W Duiker9Robbert J de Haas10R Bart Takkenberg11Alicia Furumaya12Belle V van Rosmalen13Anne J Klompenhouwer14Maarten G J Thomeer15Matthijs Kramer16Mariëlle M E Coolsen17Maarten E Tushuizen18Alexander F Schaapherder19Joris I Erdmann20ID MunstermanMD DoukasJC BeckervordersandforthR MicleaETTL TjwaPB van den BoezemJHW de WiltS van KoeverdenAE BraatMJ CoenraadSSLP CrobachS FeshtaliMC BurgmansTM van GulikR SwijnenburgKP de JongAmsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The NetherlandsDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The NetherlandsDepartment of Surgery, University Medical Centre Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Surgery, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, The NetherlandsAmsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The NetherlandsDepartment of Surgery, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsDepartment of Gastroenterology and Hepatology, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, The NetherlandsDepartment of Gastroenterology and Hepatology, University Medical Centre Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Surgery, University Medical Centre Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Radiology, University Medical Centre Groningen, University of Groningen, Groningen, The NetherlandsAmsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The NetherlandsDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The NetherlandsDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The NetherlandsDepartment of Surgery, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, The NetherlandsDepartment of Radiology, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, The NetherlandsDepartment of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht University, Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre+, Maastricht University, Maastricht, The NetherlandsDepartment of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden University, Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, Leiden University, Leiden, The NetherlandsDepartment of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The NetherlandsIntroduction Benign liver tumours and cysts (BLTCs) comprise a heterogeneous group of cystic and solid lesions, including hepatic haemangioma, focal nodular hyperplasia and hepatocellular adenoma. Some BLTCs, for example, (large) hepatocellular adenoma, are at risk of complications. Incidence of malignant degeneration or haemorrhage is low in most other BLTCs. Nevertheless, the diagnosis BLTC may carry a substantial burden and patients may be symptomatic, necessitating treatment. The indications for interventions remain matter of debate. The primary study aim is to investigate patient-reported outcomes (PROs) of patients with BLTCs, with special regards to the influence of invasive treatment as compared with the natural course of the disease.Methods and analysis A nationwide observational cohort study of patients with BLTC will be performed between October 2021 and October 2026, the minimal follow-up will be 2 years. During surveillance, a questionnaire regarding symptoms and their impact will be sent to participants on a biannual basis and more often in case of invasive intervention. The questionnaire was previously developed based on PROs considered relevant to patients with BLTCs and their caregivers. Most questionnaires will be administered by computerised adaptive testing through the Patient-Reported Outcomes Measurement Information System. Data, such as treatment outcomes, will be extracted from electronic patient files. Multivariable analysis will be performed to identify patient and tumour characteristics associated with significant improvement in PROs or a complicated postoperative course.Ethics and dissemination The study was assessed by the Medical Ethics Committee of the University Medical Center Groningen and the Amsterdam UMC. Local consultants will provide information and informed consent will be asked of all patients. Results will be published in a peer-reviewed journal.Study registration NL8231—10 December 2019; Netherlands Trial Register.https://bmjopen.bmj.com/content/12/9/e055104.full
spellingShingle Joanne Verheij
Marc G Besselink
Vincent E de Meijer
Jan N M IJzermans
D Ramsoekh
C van der Leij
Otto M van Delden
Geert Kazemier
Robert A de Man
Frans J C Cuperus
Martijn P D Haring
Evelien W Duiker
Robbert J de Haas
R Bart Takkenberg
Alicia Furumaya
Belle V van Rosmalen
Anne J Klompenhouwer
Maarten G J Thomeer
Matthijs Kramer
Mariëlle M E Coolsen
Maarten E Tushuizen
Alexander F Schaapherder
Joris I Erdmann
ID Munsterman
MD Doukas
JC Beckervordersandforth
R Miclea
ETTL Tjwa
PB van den Boezem
JHW de Wilt
S van Koeverden
AE Braat
MJ Coenraad
SSLP Crobach
S Feshtali
MC Burgmans
TM van Gulik
R Swijnenburg
KP de Jong
Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
BMJ Open
title Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
title_full Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
title_fullStr Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
title_full_unstemmed Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
title_short Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
title_sort study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the netherlands the beliver study
url https://bmjopen.bmj.com/content/12/9/e055104.full
work_keys_str_mv AT studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT joanneverheij studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT marcgbesselink studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT vincentedemeijer studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT jannmijzermans studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT dramsoekh studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT cvanderleij studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT ottomvandelden studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT geertkazemier studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT robertademan studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT fransjccuperus studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT martijnpdharing studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT evelienwduiker studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT robbertjdehaas studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT rbarttakkenberg studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT aliciafurumaya studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT bellevvanrosmalen studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT annejklompenhouwer studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT maartengjthomeer studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT matthijskramer studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT mariellemecoolsen studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT maartenetushuizen studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT alexanderfschaapherder studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT jorisierdmann studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT idmunsterman studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT mddoukas studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT jcbeckervordersandforth studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT rmiclea studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT ettltjwa studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT pbvandenboezem studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT jhwdewilt studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT svankoeverden studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT aebraat studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT mjcoenraad studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT sslpcrobach studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT sfeshtali studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT mcburgmans studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT tmvangulik studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT rswijnenburg studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy
AT kpdejong studyprotocolforamulticentrenationwideprospectivecohortstudytoinvestigatethenaturalcourseandclinicaloutcomeinbenignlivertumoursandcystsinthenetherlandsthebeliverstudy